Formulation and Evaluation of Mucoadhesive Beads of Dexamethasone
DOI:
https://doi.org/10.26452/ijcpms.v3i2.504Keywords:
Mucoadhesive beads, bio adhesion, DexamethasoneAbstract
The goal of the current study was to formulate and evaluate mucoadhesive Dexamethasone beads to significantly lengthen the duration of the drug's stay in the GI system to treat Crohn’s disease. Dexamethasone is a corticosteroid that acts as an anti-rheumatic and anti-inflammatory. To decrease the dosage frequency Dexamethasone adhesive beads were formulated for Intimate contact with the underlying absorption surface is made possible by a prolonged stay at the location, which enhances the drug's therapeutic effectiveness. In the current study, calcium chloride and aluminium chloride were utilised as cross-linking agents to create Dexamethasone mucoadhesive beads employing adhesive polymers like sodium alginate, HPMC, and Eudragit L-100. The prepared beads' entrapment efficiencies ranged from 57.15 to 99.16%. Regarding entrapment effectiveness, particle size, surface properties, and in-vitro drug release experiments, the impact of bioadhesive polymers and cross-linking ions was assessed. The MPS-7 delayed the drug's release for 12 hours, which may be related to the cross-linking agent aluminium chloride. According to drug release kinetics, all of the formulations were more linear concerning zero order (r2=0.99) than concerning first order (r2=0.751 to 0.828). Super Case 2 Transport was discovered to be the precise release mechanism.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.